Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

A breast cancer vaccine targeting a key protein showed strong immune responses in over 75 percent of its trial participants ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

A new breast cancer vaccine shows significant promise in preventing and treating the disease, particularly triple-negative ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Vaccination programs have saved lives – and saved the Canadian economy and health care system significant resources as well ...

Passion is an important word in Georgina Long’s lexicon. It’s the drive that has stamped her as an internationally renowned ...

WE are living in what experts are calling a “golden age” of cancer treatment. New medicines are being developed every year, ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

Two new observational studies highlight the outsized burden of cancer associated with human papillomavirus (HPV) among both ...